Therefore, in cancer therapy using nonsteroidal anti-inflammatory drugs (NSAIDs) including ASA that have pro-apoptotic activity, effects on the regulation of NF-κB are very important, although still controversial. This evidence concerns the gene NFKB1 and cancer.